How Biostate AI is Changing the Future of Medicine - And How You Can Invest 💡w Post

It’s Alberto here, and I hope your week is going well! I am bringing you something special to this one.

Biostate AI’s funding round is closing in just 10 days, and once it’s gone, this opportunity will be closed forever. We have given access to this raise from a close connection to us.

If you’ve been waiting for the right moment to get in on an early-stage investment with massive potential, now is the time to act. Top investors have already backed $8,000,000+ for Biostate AI, and now it’s your turn to join them and get in on this game-changing opportunity.

Why You Should Care: This Opportunity Won’t Come Again

Biostate AI is on a mission to revolutionize personalized healthcare, and they’ve already achieved some incredible milestones:

• Raised $8.1M from top investors like Accel, Anthropic, and 10X Genomics.

• Strategic partnerships with Harvard Medical School, MD Anderson, and Cornell.

• Proprietary AI models with 89% prediction accuracy in liver toxicity.

Now, Biostate is opening their final round of investment to the public, but this exclusive opportunity is only available for the next 10 days. After that, access to the campaign will be limited to institutional investors again.

Top Investors Have Already Taken Action—Why Haven’t You?

Here’s the reality: top investors have already poured millions into Biostate AI because they see the massive potential this company has to disrupt the healthcare industry.

Now, this same opportunity is available to YOU—but only for a few more days.

• The market for personalized medicine is worth $200B+.

• AI in healthcare is transforming diagnostics and drug development.

• Biostate AI is already seeing traction in clinical settings, including 8,000+ clinical samples sequenced.

The clock is ticking—you’re only 10 days away from missing out on an opportunity that could change the way healthcare works forever. Don’t sit on the sidelines while top investors are already onboard. Why wouldn’t you want to join them?

Let’s break it down.

🔬 Traction & Milestones

• $8.1M Raised to date.

• 12 pending patents on core biotech and AI technology

• 8,000+ clinical samples sequenced using Biostate’s tech

• Strategic clinical partnerships with Harvard Medical School, MD Anderson, and Cornell

• Partnership with the Accelerated Cure Project to accelerate MS research

• AI model for liver toxicity with 89% prediction accuracy

• Subsidiaries in India and China for global scalability and operational efficiency

🧠 The Team

Led by repeat deep-tech entrepreneurs with a strong academic and commercial track record:

• Dave Zhang, CEO – Former MIT professor; raised $110M+ in past biotech ventures
  

• Ashwin Gopinath, CTO – Former Caltech/MIT faculty; previously exited company for $50M+ with 4x investor return
  

• Backed by a world-class team of PhDs, clinical experts, and AI leaders from MIT, Roche, Google X, and more

🌎 Market Opportunity

Biostate is positioned at the convergence of biotech, AI, and data infrastructure, with a platform that can power clinical decisions, diagnostics, and pharma pipelines globally.

🔓 Why Now?

• AI is transforming every industry—healthcare is next

• The cost of RNA sequencing has dropped—Biostate is making it scalable

• Regulators and hospitals are increasingly embracing data-driven decision-making

• The rise of personalized medicine and value-based care demands better tools

💥 Why Biostate Could Become a Unicorn

• Addresses $200B+ problems across multiple verticals

• Defensible technology with strong IP moat

• First-mover advantage in AI-powered disease prediction at scale

• Institutional validation + early commercial traction

• Clear roadmap to clinical deployment and AI-driven diagnostics

🧩 Why This Raise is Different

Biotech startups like Biostate typically raise behind closed doors, open only to VCs and insiders.

But Biostate AI is doing it differently:
📢 They’ve opened this round to the public on Wefunder.
 🎯 So retail investors can invest at the same valuation as institutional investors.

🕒 This is the final month the round will be open. Once it closes, access will be limited to institutional capital again.

🚀 How to Invest

Minimum investment: $100
Platform: Wefunder
Status: Open – Final Month

🔴 Invest now on Wefunder

Next Steps for Investors:

You know the clock is ticking, and this once-in-a-lifetime opportunity to invest in Biostate AI is closing in just 10 days. Top investors are already onboard, and now is your chance to join them before the doors close.

This is your last chance to get in on the ground floor of a company that could transform the future of healthcare. Act now, or miss out on this exclusive opportunity forever.

Invest today → Biostate AI on Wefunder

Cheers,
Alberto
CEO, Founderscrowd

Helping You Find the Next Big Thing in Startups.